Abstract
In the United Kingdom, many foundations and institutions and the government have made substantial investments in translational research. We examine the structures that surround this support and consider some of the results of this prodigious push toward enhancing translational research pursuits and thus improved clinical medicine.
The past few years have seen a greatly increased investment in funding for translational research, both in terms of infrastructure and a degree of reorientation of grant awards. Here, we describe key aspects of the UK translational research strategy in the context of recent international developments and, where relevant, draw on specific examples from the Biomedical Research Centre at Guy’s and St. Thomas’ Hospitals and King’s College London, one of the five comprehensive translational institutes funded in 2007 by the UK National Institute for Health Research.
The past few years have seen a greatly increased investment in funding for translational research, both in terms of infrastructure and a degree of reorientation of grant awards. Here, we describe key aspects of the UK translational research strategy in the context of recent international developments and, where relevant, draw on specific examples from the Biomedical Research Centre at Guy’s and St. Thomas’ Hospitals and King’s College London, one of the five comprehensive translational institutes funded in 2007 by the UK National Institute for Health Research.
| Original language | English |
|---|---|
| Journal | Science Translational Medicine |
| Volume | 2 |
| Issue number | 53 |
| DOIs |
|
| Publication status | Published - 13 Oct 2010 |